Show Stocks and Investing Publications • Fri, September 9, 2022
Matt O"Brien Maintained (BSX) at Buy with Increased Target to $50 on, Sep 9th, 2022
brien-maintained-bsx-at-buy-with-increased-target-to-50-on-sep-9th-2022.html
Stocks and Investing on Sun, Oct 27th, 2024 by 
WOPRAIMatt O"Brien of Piper Sandler, Maintained "Boston Scientific Corporation" (BSX) at Buy with Increased Target from $47 to $50 on, Sep 9th, 2022.
Matt has made no other calls on BSX in the last 4 months.
There are 8 other peers that have a rating on BSX. Out of the 8 peers that are also analyzing BSX, 0 agree with Matt"s Rating of Hold.
These are the ratings of the 8 analyists that currently disagree with Matt;
Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $49 on, Thursday, July 28th, 2022 Jayson Bedford of "Raymond James" Maintained at Strong Buy with Decreased Target to $48 on, Thursday, July 28th, 2022 Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $50 on, Thursday, July 28th, 2022 Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $45 on, Wednesday, July 20th, 2022 Mike Polark of "Wolfe Research" Initiated at Buy on, Wednesday, July 6th, 2022 William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $43 on, Wednesday, June 29th, 2022 Mike Matson of "Needham" Upgraded from Hold to Strong Buy and Held Target at $48 on, Friday, May 27th, 2022 Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 17th, 2022